Terms: = Kidney tumors AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC AND Treatment
9 results:
1. Report and follow-up on two new patients with congenital mesoblastic nephroma.
Serra G; Cimador M; Giuffrè M; Insinga V; Montante C; Pensabene M; Piro E; Salerno S; Schierz IAM; Corsello G
Ital J Pediatr; 2023 Sep; 49(1):124. PubMed ID: 37726782
[TBL] [Abstract] [Full Text] [Related]
2. A novel ETV6-ntrk3 gene fusion in primary renal fibrosarcoma.
Jiang H
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4705-4708. PubMed ID: 35856362
[TBL] [Abstract] [Full Text] [Related]
3. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
[TBL] [Abstract] [Full Text] [Related]
4. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
Surrey LF; Davis JL
Cancer Genet; 2022 Jan; 260-261():6-13. PubMed ID: 34794069
[TBL] [Abstract] [Full Text] [Related]
5. Pediatric Renal tumors: Updates in the Molecular Era.
Treece AL
Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers.
Carter-Febres M; Schneller N; Fair D; Solomon D; Perry A; Roy A; Linscott L; Alashari M; Kestle JR; Bruggers CS
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e987-e990. PubMed ID: 33093355
[TBL] [Abstract] [Full Text] [Related]
7. Recurrent EML4-ntrk3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
[TBL] [Abstract] [Full Text] [Related]
8. [Fibrosarcoma in children and adolescents: different entities for the same name].
Thebaud E; Mezel A; Leroy X; Orbach D
Bull Cancer; 2012 Jun; 99(6):715-22. PubMed ID: 22640917
[TBL] [Abstract] [Full Text] [Related]
9. Non-resectable congenital tumors with the ETV6-ntrk3 gene fusion are highly responsive to chemotherapy.
McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
[TBL] [Abstract] [Full Text] [Related]
